Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)

Tasci, Elif SenocakOyan, BasakSonmez, OzlemMutlu, Arda UlasAtci, Muhammed MustafaSakin, AbdullahOner, Irem2024-02-232024-02-2320241471-2407https://doi.org/10.1186/s12885-024-11863-0https://hdl.handle.net/20.500.12452/14540[Abstract Not Availabe]eninfo:eu-repo/semantics/openAccess[Keyword Not Available]Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)Correction241382629622-s2.0-85182828807WOS:00114830020000210.1186/s12885-024-11863-0